Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-179.81M
↓ 105% below average
Average (9y)
$-87.62M
Historical baseline
Range
High:$183.87M
Low:$-185.62M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-179.81M | -10.7% |
| 2023 | $-162.37M | -80.1% |
| 2022 | $-90.18M | -2.2% |
| 2021 | $-88.24M | +38.3% |
| 2020 | $-143.06M | -225.8% |
| 2019 | $113.74M | +176.5% |
| 2018 | $-148.70M | +19.9% |
| 2017 | $-185.62M | -5.6% |
| 2016 | $-175.86M | -195.6% |
| 2015 | $183.87M | - |